Cargando…

Global N-linked Glycosylation is Not Significantly Impaired in Myoblasts in Congenital Myasthenic Syndromes Caused by Defective Glutamine-Fructose-6-Phosphate Transaminase 1 (GFPT1)

Glutamine-fructose-6-phosphate transaminase 1 (GFPT1) is the first enzyme of the hexosamine biosynthetic pathway. It transfers an amino group from glutamine to fructose-6-phosphate to yield glucosamine-6-phosphate, thus providing the precursor for uridine diphosphate N-acetylglucosamine (UDP-GlcNAc)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Qiushi, Müller, Juliane S., Pang, Poh-Choo, Laval, Steve H., Haslam, Stuart M., Lochmüller, Hanns, Dell, Anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693256/ https://www.ncbi.nlm.nih.gov/pubmed/26501342 http://dx.doi.org/10.3390/biom5042758

Ejemplares similares

Glutamine-Fructose-6-Phosphate Transaminase 2 (GFPT2) Is Upregulated in Breast Epithelial–Mesenchymal Transition and Responds to Oxidative Stress
por: Wang, Qiong, et al.
Publicado: (2021)

Congenital myasthenic syndrome caused by a frameshift insertion mutation in GFPT1
por: Szelinger, Szabolcs, et al.
Publicado: (2020)

GFPT1 deficiency in muscle leads to myasthenia and myopathy in mice
por: Issop, Yasmin, et al.
Publicado: (2018)

Cancer‐associated fibroblast expression of glutamine fructose‐6‐phosphate aminotransferase 2 (GFPT2) is a prognostic marker in gastric cancer
por: Yang, Shuo, et al.
Publicado: (2023)

Abnormal decrement on high-frequency repetitive nerve stimulation in congenital myasthenic syndrome with GFPT1 mutations and review of literature
por: An, Ran, et al.
Publicado: (2022)

Identification of mutations in the MYO9A gene in patients with congenital myasthenic syndrome
por: O’Connor, Emily, et al.
Publicado: (2016)

Congenital Myasthenic Syndromes with Predominant Limb Girdle Weakness
por: Evangelista, Teresinha, et al.
Publicado: (2015)

The beta-adrenergic agonist salbutamol modulates neuromuscular junction formation in zebrafish models of human myasthenic syndromes
por: McMacken, Grace, et al.
Publicado: (2018)

Targeted therapies for congenital myasthenic syndromes: systematic review and steps towards a treatabolome
por: Thompson, Rachel, et al.
Publicado: (2019)

Congenital myasthenic syndromes due to mutations in ALG2 and ALG14
por: Cossins, Judith, et al.
Publicado: (2013)

Diverse myopathological features in the congenital myasthenia syndrome with GFPT1 mutation
por: Jiang, Kaiyan, et al.
Publicado: (2022)

Kynurenine aminotransferase 3/glutamine transaminase L/cysteine conjugate beta-lyase 2 is a major glutamine transaminase in the mouse kidney
por: Yang, Cihan, et al.
Publicado: (2016)

Mitochondrial Mutations Can Alter Neuromuscular Transmission in Congenital Myasthenic Syndrome and Mitochondrial Disease
por: O’Connor, Kaela, et al.
Publicado: (2023)

Presynaptic Congenital Myasthenic Syndromes: Understanding Clinical Phenotypes through In vivo Models
por: Pugliese, Alessia, et al.
Publicado: (2023)

NF-κB upregulates glutamine-fructose-6-phosphate transaminase 2 to promote migration in non-small cell lung cancer
por: Szymura, Szymon J., et al.
Publicado: (2019)

Characterisation of a novel cardiac phenotype in patients with GFPT1 or DPAGT1 mutations
por: Lewis, Andrew, et al.
Publicado: (2014)

Congenital Myasthenic Syndromes or Inherited Disorders of Neuromuscular Transmission: Recent Discoveries and Open Questions
por: Nicole, Sophie, et al.
Publicado: (2017)

Mutations in GMPPB cause congenital myasthenic syndrome and bridge myasthenic disorders with dystroglycanopathies
por: Belaya, Katsiaryna, et al.
Publicado: (2015)

A nomenclature and classification for the congenital myasthenic syndromes: preparing for FAIR data in the genomic era
por: Thompson, Rachel, et al.
Publicado: (2018)

High GFPT1 expression predicts unfavorable outcomes in patients with resectable pancreatic ductal adenocarcinoma
por: Gong, Yitao, et al.
Publicado: (2021)

Intragenic DOK7 deletion detected by whole-genome sequencing in congenital myasthenic syndromes
por: Azuma, Yoshiteru, et al.
Publicado: (2017)

Salbutamol-responsive limb-girdle congenital myasthenic syndrome due to a novel missense mutation and heteroallelic deletion in MUSK
por: Gallenmüller, Constanze, et al.
Publicado: (2014)

Congenital myasthenic syndrome with episodic apnoea: clinical, neurophysiological and genetic features in the long-term follow-up of 19 patients
por: McMacken, Grace, et al.
Publicado: (2017)

Splicing regulation of GFPT1 muscle-specific isoform and its roles in glucose metabolisms and neuromuscular junction
por: Farshadyeganeh, Paniz, et al.
Publicado: (2023)

Long Term Follow-Up on Pediatric Cases With Congenital Myasthenic Syndromes—A Retrospective Single Centre Cohort Study
por: Della Marina, Adela, et al.
Publicado: (2020)

Roles of GFPT2 Expression Levels on the Prognosis and Tumor Microenvironment of Colon Cancer
por: Ding, Xiaorong, et al.
Publicado: (2022)

Salbutamol modifies the neuromuscular junction in a mouse model of ColQ myasthenic syndrome
por: McMacken, Grace M, et al.
Publicado: (2019)

Altered glycosylation of glycodelin in endometrial carcinoma
por: Hautala, Laura C., et al.
Publicado: (2020)

GFPT2/GFAT2 and AMDHD2 act in tandem to control the hexosamine pathway
por: Kroef, Virginia, et al.
Publicado: (2022)

Congenital myasthenic syndrome in a cohort of patients with ‘double’ seronegative myasthenia gravis
por: Lorenzoni, Paulo José, et al.
Publicado: (2021)

Mutations in gfpt1 and skiv2l2 Cause Distinct Stage-Specific Defects in Larval Melanocyte Regeneration in Zebrafish
por: Yang, Chao-Tsung, et al.
Publicado: (2007)

Congenital myasthenic syndrome with mild intellectual disability caused by a recurrent SLC25A1 variant
por: Balaraju, Sunitha, et al.
Publicado: (2019)

Maternal-derived galectin-1 shapes the placenta niche through Sda terminal glycosylation: Implication for preeclampsia
por: Xie, Yiran, et al.
Publicado: (2023)

Metabolic Heterogeneity, Plasticity, and Adaptation to “Glutamine Addiction” in Cancer Cells: The Role of Glutaminase and the GTωA [Glutamine Transaminase—ω-Amidase (Glutaminase II)] Pathway
por: Cooper, Arthur J. L., et al.
Publicado: (2023)

Severe congenital myasthenic syndromes caused by agrin mutations affecting secretion by motoneurons
por: Jacquier, Arnaud, et al.
Publicado: (2022)

Drosophila studies support a role for a presynaptic synaptotagmin mutation in a human congenital myasthenic syndrome
por: Shields, Mallory C., et al.
Publicado: (2017)

Modulation of the Acetylcholine Receptor Clustering Pathway Improves Neuromuscular Junction Structure and Muscle Strength in a Mouse Model of Congenital Myasthenic Syndrome
por: Spendiff, Sally, et al.
Publicado: (2020)

Fructose reprogrammes glutamine-dependent oxidative metabolism to support LPS-induced inflammation
por: Jones, Nicholas, et al.
Publicado: (2021)

Myasthenic Crisis In Pregnancy
por: French, David M., et al.
Publicado: (2017)

Congenital myasthenic syndromes
por: Finsterer, Josef
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lfakhm17a6afs4c54vme2h9vpq